REQUEST A DEMO
Total
USD $0.00
Search more companies

Somed Cr Sp. z o.o. (Poland)

Main Activities: General Medical and Surgical Hospitals
Secondary Activities: Research and Development in Biotechnology (except Nanobiotechnology) | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | All Other Miscellaneous Schools and Instruction | Ambulatory Health Care Services | Outpatient Care Centers
Full name: Somed Cr Sp. z o.o. Profile Updated: December 12, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Somed Cr Sp. z o.o. is an enterprise located in Poland, with the main office in Warsaw. The company operates in the General Medical and Surgical Hospitals sector. The enterprise was incorporated on October 03, 2019. Its’ total assets recorded a growth of 1.63%.

Headquarters
Ul. Adama Mickiewicza 25/36
Warsaw; Mazowieckie; Postal Code: 01-551

Contact Details: Purchase the Somed Cr Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Somed Cr Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Somed Cr Sp. z o.o. report to view the information.
Incorporation Date:
October 03, 2019
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
99%
Subsidiaries
Specjalistyczny Osrodek Medycyny Wieku Dojrzalego Sp. z o.o.
11.11%
Company Performance
Financial values in the chart are available after Somed Cr Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Total operating revenue
777.96%
Operating profit (EBIT)
833.47%
Net Profit (Loss) for the Period
833.47%
Total assets
1.63%
Total equity
1.63%
Return on Equity (ROE)
1.43%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?